132 related articles for article (PubMed ID: 38786326)
1. Impact of CDK Inhibitors on
Bette S; Haase L; Nell J; Grieser T; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TFE; Mellert K
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786326
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
Cottone L; Cribbs AP; Khandelwal G; Wells G; Ligammari L; Philpott M; Tumber A; Lombard P; Hookway ES; Szommer T; Johansson C; Brennan PE; Pillay N; Jenner RG; Oppermann U; Flanagan AM
Cancer Res; 2020 Oct; 80(20):4540-4551. PubMed ID: 32855205
[TBL] [Abstract][Full Text] [Related]
3. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
[TBL] [Abstract][Full Text] [Related]
4. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
[TBL] [Abstract][Full Text] [Related]
5. [Chordoma: is there a molecular basis for diagnosis and treatment?].
Scheipl S; Igrec J; Leithner A; Smolle M; Haybäck J; Liegl B
Pathologe; 2020 Mar; 41(2):153-162. PubMed ID: 32100085
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule targeting of brachyury transcription factor addiction in chordoma.
Sharifnia T; Wawer MJ; Chen T; Huang QY; Weir BA; Sizemore A; Lawlor MA; Goodale A; Cowley GS; Vazquez F; Ott CJ; Francis JM; Sassi S; Cogswell P; Sheppard HE; Zhang T; Gray NS; Clarke PA; Blagg J; Workman P; Sommer J; Hornicek F; Root DE; Hahn WC; Bradner JE; Wong KK; Clemons PA; Lin CY; Kotz JD; Schreiber SL
Nat Med; 2019 Feb; 25(2):292-300. PubMed ID: 30664779
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a novel chordoma cell line: CH22.
Liu X; Nielsen GP; Rosenberg AE; Waterman PR; Yang W; Choy E; Sassi S; Yang S; Harmon DC; Yang C; Schwab JH; Kobayashi E; Mankin HJ; Xavier R; Weissleder R; Duan Z; Hornicek FJ
J Orthop Res; 2012 Oct; 30(10):1666-73. PubMed ID: 22504929
[TBL] [Abstract][Full Text] [Related]
8. Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line.
Pagani F; Gryzik M; Somenza E; Cominelli M; Balzarini P; Schreiber A; Mattavelli D; Nicolai P; Doglietto F; Poliani PL
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983607
[TBL] [Abstract][Full Text] [Related]
9. Multiple malignant tumors in a patient with familial chordoma, a case report.
Sumransub N; Murugan P; Marette S; Clohisy DR; Skubitz KM
BMC Med Genomics; 2021 Aug; 14(1):213. PubMed ID: 34465320
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput/High Content Imaging Screen Identifies Novel Small Molecule Inhibitors and Immunoproteasomes as Therapeutic Targets for Chordoma.
Ajay AK; Chu P; Patel P; Deban C; Roychowdhury C; Heda R; Halawi A; Saad A; Younis N; Zhang H; Jiang X; Nasr M; Hsiao LL; Lin G; Azzi JR
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111759
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Profiling Supports the Notochordal Origin of Chordoma and Its Dependence on a TGFB1-TBXT Network.
Halvorsen SC; Benita Y; Hopton M; Hoppe B; Gunnlaugsson HO; Korgaonkar P; Vanderburg CR; Nielsen GP; Trepanowski N; Cheah JH; Frosch MP; Schwab JH; Rosenberg AE; Hornicek FJ; Sassi S
Am J Pathol; 2023 May; 193(5):532-547. PubMed ID: 36804377
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.
O'donnell P; Tirabosco R; Vujovic S; Bartlett W; Briggs TW; Henderson S; Boshoff C; Flanagan AM
Skeletal Radiol; 2007 Jan; 36(1):59-65. PubMed ID: 16810540
[TBL] [Abstract][Full Text] [Related]
13. Molecular features and vulnerabilities of recurrent chordomas.
Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
[TBL] [Abstract][Full Text] [Related]
14. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic targets in chordoma.
Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
[TBL] [Abstract][Full Text] [Related]
17. UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.
Owen JH; Komarck CM; Wang AC; Abuzeid WM; Keep RF; McKean EL; Sullivan S; Fan X; Prince MEP
J Neurosurg; 2018 Mar; 128(3):701-709. PubMed ID: 28430034
[TBL] [Abstract][Full Text] [Related]
18. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
[TBL] [Abstract][Full Text] [Related]
19. Inhibition Of Glycogen Synthase Kinase 3 Beta Suppresses The Growth And Survival Of Skull Base Chordoma Cells By Downregulating Brachyury Expression.
Yan X; Li Z; Li H; Liu P; Zhao Z; Cheng S; Wang Z; Zhang Q
Onco Targets Ther; 2019; 12():9783-9791. PubMed ID: 31819479
[TBL] [Abstract][Full Text] [Related]
20. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity.
Sheppard HE; Dall'Agnese A; Park WD; Shamim MH; Dubrulle J; Johnson HL; Stossi F; Cogswell P; Sommer J; Levy J; Sharifnia T; Wawer MJ; Nabet B; Gray NS; Clemons PA; Schreiber SL; Workman P; Young RA; Lin CY
Cell Rep Med; 2021 Jan; 2(1):100188. PubMed ID: 33521702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
